Back to Article
Lifecycle Management as a Roadmap to the Tobacco Endgame
World Journal of Clinical Medicine Research
| Vol 5, Issue 1
Table 8. Risk and Countermeasure Matrix Across theLifecycle
| Risk Category | Leading Indicators / Triggers | Likely Impacted Phases |
| Litigation & Preemption | Court injunctions; state preemption bills introduced | 2 Design; 4 Evaluation; 5 Consolidation |
| Industry Product Pivot | Surge in disposables or heated products; flavor substitutions | 3 Implementation; 4 Evaluation |
| Enforcement Gaps | Inspection backlogs; weak penalties for repeat violators | 3 Implementation; 4 Evaluation |
| Misinformation / Social Media | Viral pro-vape content; youth influencer marketing | 1 Conception; 3 Implementation; 6 Sustainment |
| Equity Backfire | Cessation access gaps; menthol substitution | 3 Implementation; 5 Consolidation |
| Supply Chain Leakage | Cross-border sales; illicit markets growth | 5 Consolidation; 6 Sustainment |
| Political Volatility | Policy repeals; leadership turnover | 1 Conception; 5 Consolidation |